methyl 4-hydroxy-6-(trimethylsilyl)-5-hexynoate | 118800-11-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl 4-hydroxy-6-(trimethylsilyl)-5-hexynoate
• 英文别名: 4-hydroxy-6-(trimethylsilyl)hex-5-ynoic acid methyl ester；4-hydroxy-6-trimethylsilanyl-hex-5-ynoic acid methyl ester；methyl 4-hydroxy-6-trimethylsilylhex-5-ynoate
• CAS: 118800-11-6
• 化学式: C₁₀H₁₈O₃Si
• 分子量: 214.337
• InChiKey: VMVWFJDZNOOKIW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.18
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 4-hydroxy-6-(trimethylsilyl)-5-hexynoate 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 5.0h， 以77%的产率得到6-Trimethylsilylhex-5-yn-1,4-diol
  参考文献：
  名称：

  （S）-γ-炔属γ-氨基丁酸（GABA）的对映选择性合成

  摘要：

  据报道，通过（R）-丙-2-炔醇12（由缩醛4生成）的邻苯二甲酰亚胺置换，合成了（S）-γ-炔属γ-氨基丁酸（GABA）1。

  DOI：

  10.1039/p19910003301
• 作为产物：
  描述：

  丁二酸单甲酯酰氯 在 sodium tetrahydroborate 、 三氯化铝 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 4.33h， 生成 methyl 4-hydroxy-6-(trimethylsilyl)-5-hexynoate
  参考文献：
  名称：

  （S）-γ-炔属γ-氨基丁酸（GABA）的对映选择性合成

  摘要：

  据报道，通过（R）-丙-2-炔醇12（由缩醛4生成）的邻苯二甲酰亚胺置换，合成了（S）-γ-炔属γ-氨基丁酸（GABA）1。

  DOI：

  10.1039/p19910003301

文献信息

• [EN] FATTY ACID DERIVATIVES AND THEIR USE<br/>[FR] DÉRIVÉS D'ACIDES GRAS ET UTILISATION ASSOCIÉE
  申请人：US HEALTH

  公开号：WO2019010414A1

  公开（公告）日：2019-01-10

  This disclosure concerns fatty acid derivatives, pharmaceutical compositions comprising the fatty acid derivatives, and methods of using the fatty acid derivatives, for example, to treat inflammation, chronic itch, chronic pain, an autoimmune disorder, atherosclerosis, a skin disorder, arthritis, a neurodegenerative disorder, or a psychiatric disorder in a subject. In some embodiments, the fatty acid derivative is a compound, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, having a structure according to: (I) wherein X is from 1-16 carbons in length, Z is aliphatic from 1-16 carbons in length, or is not present, Y is selected from: (II) R1, R2, and R3 are independently hydrogen or lower alkyl, R4 is lower alkyl, hydroxyl, carboxyl, or amine, R5 is hydrogen, lower alkyl, or halide, R6 is hydroxyl or substituted thiol, and each R7 is independently hydrogen or fluoride or is not present and the adjacent carbons form alkyne.

  这份披露涉及脂肪酸衍生物，包括含有脂肪酸衍生物的药物组合物，以及使用脂肪酸衍生物的方法，例如用于治疗炎症、慢性瘙痒、慢性疼痛、自身免疫性疾病、动脉粥样硬化、皮肤疾病、关节炎、神经退行性疾病或精神疾病的主体。在某些实施例中，脂肪酸衍生物是一种化合物，或其立体异构体、互变异构体或药用可接受的盐，其结构如下：(I)其中X的长度为1-16个碳，Z是1-16个碳的脂肪族，或者不存在，Y选自：(II)R1、R2和R3独立地是氢或较低的烷基，R4是较低的烷基、羟基、羧基或胺基，R5是氢、较低的烷基或卤素，R6是羟基或取代硫醇，每个R7独立地是氢或氟或不存在，相邻的碳形成炔烃。
• Conformationally restricted analogs of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide
  作者：J. R. Michael Lundkvist、Bjorn Ringdahl、Uli Hacksell

  DOI：10.1021/jm00124a022

  日期：1989.4

  Conformationally restricted analogues of the selective partial muscarinic agonist N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM 5; 2) were synthesized. The compounds were tested for muscarinic and antimuscarinic activity in the isolated guinea pig ileum and in intact mice. They were found to be moderately potent muscarinic antagonists or weak partial agonists. The new compounds were less potent than 2 in inhibiting (-)-[3H]-N-methylscopolamine binding in the rate cerebral cortex. Thus, structural modifications of 2 in which part of the amide moiety has been connected with the methyl group in the butynyl chain to form a five-membered ring decrease affinity and in most cases abolish efficacy.
• LUNDKVIST, J. R. MICHAEL;RINGDAHL, BJORN;HACKSELL, ULI, J. MED. CHEM., 32,(1989) N, C. 863-869
  作者：LUNDKVIST, J. R. MICHAEL、RINGDAHL, BJORN、HACKSELL, ULI

  DOI：——

  日期：——
• Enantioselective synthesis of (S)-γ-acetylenic γ-aminobutyric acid (GABA)
  作者：Andrew B. Holmes、Alethea B. Tabor、Raymond Baker

  DOI：10.1039/p19910003301

  日期：——

  The enantioselective synthesis of (S)-γ-acetylenic γ-aminobutyric acid (GABA)1 by phthalimide displacement of the (R)-prop-2-ynylic alcohol 12(generated from acetal 4) is reported.

  据报道，通过（R）-丙-2-炔醇12（由缩醛4生成）的邻苯二甲酰亚胺置换，合成了（S）-γ-炔属γ-氨基丁酸（GABA）1。